Osborne Ck
About
In The Last Decade
Osborne Ck
8 papers receiving 374 citations
Peers
Comparison fields: 5 of 62
- Oncology 185
- Molecular Biology 180
- Genetics 164
- Cancer Research 136
- Endocrinology, Diabetes and Metabolism 42
Countries citing papers authored by Osborne Ck
This map shows the geographic impact of Osborne Ck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osborne Ck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osborne Ck more than expected).
Fields of papers citing papers by Osborne Ck
This network shows the impact of papers produced by Osborne Ck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osborne Ck. The network helps show where Osborne Ck may publish in the future.
Co-authorship network of co-authors of Osborne Ck
This figure shows the co-authorship network connecting the top 25 collaborators of Osborne Ck. A scholar is included among the top collaborators of Osborne Ck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osborne Ck. Osborne Ck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin (DAB389EGF). | 2 |
| 2 | Prognostic factors in breast cancer. | 69 |
| 3 | Chemotherapy versus observation in high-risk node-negative breast cancer patients. | 5 |
| 4 | Adjuvant treatment of node-negative breast cancer. | 5 |
| 5 | Heterogeneity in hormone receptor status in primary and metastatic breast cancer. | 57 |
| 6 | Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. | 90 |
| 7 | Steroid hormone receptors in the management of human breast cancer. | 51 |
| 8 | Correlation Among Insulin Binding, Degradation, and Biological Activity in Human Breast Cancer Cells in Long-Term Tissue Culture | 117 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.